Sepsis – What’s New in 2019 Current Opinion Review (2019) Mark E. Nunnally

Description

Analysis of the implications of Sepsis-3 guidelines, focusing on the re-evaluation of traditional therapies such as crystalloid fluids and steroids. It explores novel therapeutic options including angiotensin II, vitamin C, and thiamine, and the utility of procalcitonin (PCT) for managing antibiotics. The review discusses the shift from noninfectious inflammatory processes to the emphasis on a dysregulated host response to infection.